Viral Infection Increases Glucocorticoid-Induced Interleukin-10 Production through ERK-Mediated Phosphorylation of the Glucocorticoid Receptor in Dendritic Cells: Potential Clinical Implications

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ng, Sinnie Sin Man ^a,b,c   Li, Andrew ^a   Pavlakis, George N ^c   Ozato, Keiko ^a   Kino, Tomoshige ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 10; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PER1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DENDRITIC CELL; DUAL SPECIFICITY PHOSPHATASE 1 GENE; FEMALE; GENE; GENE EXPRESSION; GLUCOCORTICOID INDUCED LEUCINE ZIPPER GENE; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PERIOD 1 GENE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOLL LIKE RECEPTOR SIGNALING PATHWAY; VIRUS INFECTION;

EID: 84877291898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063587     Document Type: Article

References (56)

1. Sapolsky RM, Romero LM, Munck AU, (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21: 55-89.
2. Kino T, Chrousos GP, (2007) Virus-mediated modulation of the host endocrine signaling systems: clinical implications. Trends Endocrinol Metab 18: 159-166.
3. Chrousos GP, Kino T, (2005) Interactive functional specificity of the stress and immune responses: the ying, the yang, and the defense against 2 major classes of bacteria. J Infect Dis 192: 551-555.
4. Elenkov IJ, (2004) Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 1024: 138-146.
5. Elenkov IJ, Chrousos GP, (1999) Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 10: 359-368.
6. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE, (1993) Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 119: 1198-1208.
7. Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, et al. (2006) International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev 58: 782-797.
8. Chrousos GP, Kino T, (2009) Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann N Y Acad Sci 1179: 153-166.
9. Steinman RM, Banchereau J, (2007) Taking dendritic cells into medicine. Nature 449: 419-426.
10. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
11. Steinman RM, Hemmi H (2006) Dendritic cells: Translating innate to adaptive immunity. Curr Top Microbiol Immunol. 17-58.
12. Honda K, Sakaguchi S, Nakajima C, Watanabe A, Yanai H, et al. (2003) Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci U S A 100: 10872-10877.
13. Samarasinghe R, Tailor P, Tamura T, Kaisho T, Akira S, et al. (2006) Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling. J Interferon Cytokine Res 26: 893-900.
14. Medzhitov R, (2010) Inflammation 2010: new adventures of an old flame. Cell 140: 771-776.
15. Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, et al. (2006) Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203: 2461-2472.
16. Godbout JP, Glaser R, (2006) Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol 1: 421-427.
17. Tailor P, Tamura T, Kong HJ, Kubota T, Kubota M, et al. (2007) The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 27: 228-239.
18. Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH, (2007) Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 179: 7577-7584.
19. Kino T, Ichijo T, Amin ND, Kesavapany S, Wang Y, et al. (2007) Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 21: 1552-1568.
20. Tone M, Powell MJ, Tone Y, Thompson SA, Waldmann H, (2000) IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol 165: 286-291.
21. Nader N, Ng SS, Wang Y, Abel BS, Chrousos GP, et al. (2012) Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism. PLoS One 7: e26751.
22. Jung ID, Jeong YI, Lee CM, Noh KT, Jeong SK, et al. (2010) COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells. Int Immunopharmacol 10: 760-768.
23. Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, et al. (2002) Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100: 1362-1372.
24. Morelli AE, Thomson AW, (2003) Dendritic cells under the spell of prostaglandins. Trends Immunol 24: 108-111.
25. Bowie AG, Unterholzner L, (2008) Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8: 911-922.
26. Couper KN, Blount DG, Riley EM, (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777.
27. Murray PJ, (2006) Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6: 379-386.
28. Schroder K, Hertzog PJ, Ravasi T, Hume DA, (2004) Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189.
29. Menconi M, Gonnella P, Petkova V, Lecker S, Hasselgren PO, (2008) Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes. J Cell Biochem 105: 353-364.
30. Smit JJ, Lindell DM, Boon L, Kool M, Lambrecht BN, et al. (2008) The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PLoS One 3: e1720.
31. Boonstra A, Rajsbaum R, Holman M, Marques R, Asselin-Paturel C, et al. (2006) Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J immunol 177: 7551-7558.
32. Honer C, Nam K, Fink C, Marshall P, Ksander G, et al. (2003) Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol 63: 1012-1020.
33. Redpath S, Angulo A, Gascoigne NR, Ghazal P, (1999) Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol 162: 6701-6707.
34. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, et al. (2004) A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172: 4733-4743.
35. Goldsmith M, Avni D, Ernst O, Glucksam Y, Levy-Rimler G, et al. (2009) Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways. Mol Immunol 46: 1979-1987.
36. Park JM, Greten FR, Wong A, Westrick RJ, Arthur JS, et al. (2005) Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and as key regulators. Immunity 23: 319-329.
37. Unterberger C, Staples KJ, Smallie T, Williams L, Foxwell B, et al. (2008) Role of STAT3 in glucocorticoid-induced expression of the human IL-10 gene. Mol Immunol 45: 3230-3237.
38. Tarrega C, Rios P, Cejudo-Marin R, Blanco-Aparicio C, van den Berk L, et al. (2005) ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1. J Biol Chem 280: 37885-37894.
39. Kino T, (2007) Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids. Horm Metab Res 39: 420-424.
40. Mege JL, Meghari S, Honstettre A, Capo C, Raoult D, (2006) The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis 6: 557-569.
41. Takayama T, Tahara H, Thomson AW, (2001) Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth. Transplantation 71: 1334-1340.
42. Sacher T, Mohr CA, Weyn A, Schlichting C, Koszinowski UH, et al. (2012) The role of cell types in cytomegalovirus infection in vivo. Eur J Cell Biol 91: 70-77.
43. Rosenkranz MA, Busse WW, Johnstone T, Swenson CA, Crisafi GM, et al. (2005) Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc Natl Acad Sci U S A 102: 13319-13324.
44. Marshall GD Jr, Agarwal SK, (2000) Stress, immune regulation, and immunity: applications for asthma. Allergy Asthma Proc 21: 241-246.
45. Agarwal SK, Marshall GD Jr, (1998) Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction. J Interferon Cytokine Res 18: 1059-1068.
46. Xiang L, Marshall GD Jr, (2011) Immunomodulatory effects of in vitro stress hormones on FoxP3, Th1/Th2 cytokine and costimulatory molecule mRNA expression in human peripheral blood mononuclear cells. Neuroimmunomodulation 18: 1-10.
47. Busse WW, Lemanske RF Jr, Gern JE, (2010) Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376: 826-834.
48. Mallia P, Johnston SL, (2006) How viral infections cause exacerbation of airway diseases. Chest 130: 1203-1210.
49. Maggi LB Jr, Moran JM, Buller RM, Corbett JA, (2003) ERK activation is required for double-stranded RNA- and virus-induced interleukin-1 expression by macrophages. J Biol Chem 278: 16683-16689.
50. Monick M, Staber J, Thomas K, Hunninghake G, (2001) Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase. J Immunol 166: 2681-2687.
51. Monick MM, Cameron K, Staber J, Powers LS, Yarovinsky TO, et al. (2005) Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J Biol Chem 280: 2147-2158.
52. Unterberger C, Staples KJ, Smallie T, Williams L, Foxwell B, et al. (2008) Role of STAT3 in glucocorticoid-induced expression of the human IL-10 gene. Mol Immunol 45: 3230-3237.
53. Yoneyama M, Fujita T, (2007) Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem 282: 15315-15318.
54. Tamassia N, Le Moigne V, Rossato M, Donini M, McCartney S, et al. (2008) Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. J Immunol 181: 6563-6573.
55. Nader N, Ng SS, Lambrou GI, Pervanidou P, Wang Y, et al. (2010) AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Mol Endocrinol 24: 1748-1764.
56. Hinzey A, Alexander J, Corry J, Adams KM, Claggett AM, et al. (2011) Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation. Endocrinology 152: 483-494.